University of Rochester, Golisano Children's Hospital, 601 Elmwood Ave, Rochester, NY 14642, USA.
Nationwide Children's Hospital Division of Neurology, 700 Children's Dr., Columbus, OH 43205, USA.
Mol Genet Metab. 2021 Sep-Oct;134(1-2):53-59. doi: 10.1016/j.ymgme.2021.03.016. Epub 2021 Apr 3.
To provide updated evidence and consensus-based recommendations for the classification of individuals who screen positive for Krabbe Disease (KD) and recommendations for long-term follow-up for those who are at risk for late onset Krabbe Disease (LOKD).
KD experts (KD NBS Council) met between July 2017 and June 2020 to develop consensus-based classification and follow-up recommendations. The resulting newly proposed recommendations were assessed in a historical cohort of 47 newborns from New York State who were originally classified at moderate or high risk for LOKD.
Infants identified by newborn screening with possible KD should enter one of three clinical follow-up pathways (Early infantile KD, at-risk for LOKD, or unaffected), based on galactocerebrosidase (GALC) activity, psychosine concentration, and GALC genotype. Patients considered at-risk for LOKD based on low GALC activity and an intermediate psychosine concentration are further split into a high-risk or low-risk follow-up pathway based on genotype. Review of the historical New York State cohort found that the updated follow-up recommendations would reduce follow up testing by 88%.
The KD NBS Council has presented updated consensus recommendations for efficient and effective classification and follow-up of NBS positive patients with a focus on long-term follow-up of those at-risk for LOKD.
为 Krabbe 病(KD)筛查阳性个体的分类提供最新证据和基于共识的建议,并为有迟发性 Krabbe 病(LOKD)风险的患者提供长期随访建议。
KD 专家(KD NBS 委员会)于 2017 年 7 月至 2020 年 6 月期间举行会议,制定基于共识的分类和随访建议。对来自纽约州的 47 名新生儿的历史队列进行了新提出的建议的评估,这些新生儿最初被归类为中度或高度有 LOKD 风险。
根据半乳糖脑苷脂酶(GALC)活性、神经肌醇浓度和 GALC 基因型,通过新生儿筛查发现可能患有 KD 的婴儿应进入以下三种临床随访途径之一(早发性婴儿 KD、有 LOKD 风险或未受影响)。根据低 GALC 活性和中间神经肌醇浓度被认为有 LOKD 风险的患者,根据基因型进一步分为高风险或低风险随访途径。对纽约州历史队列的回顾发现,更新后的随访建议将减少 88%的随访测试。
KD NBS 委员会提出了更新的共识建议,用于有效和高效地分类和随访 NBS 阳性患者,重点是对有 LOKD 风险的患者进行长期随访。